US 12428489
Human PD-L2 antibodies and methods of use therefor
granted A61KA61K2039/505A61P
Quick answer
US patent 12428489 (Human PD-L2 antibodies and methods of use therefor) held by The Board of Regents of the University of Texas System expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00